
Karuna Therapeutics KRTX
Geschäftsbericht 2023
hinzugefügt 22.02.2024
Karuna Therapeutics EBITDA per Share 2011-2026 | KRTX
EBITDA per Share Jährlich Karuna Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.3 | -9.12 | -4.92 | -2.71 | -3.79 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.71 | -13.3 | -6.78 |
EBITDA per Share Vierteljährlich Karuna Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -3.12 | - | -2.48 | -2.16 | -1.96 | - | -1.72 | -1.17 | -1.07 | - | -0.73 | -0.68 | -0.39 | - | -0.43 | -145 | -4.32 K | - | -494 K | -202 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.39 | -494 K | -46.7 K |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Nanobiotix S.A.
NBTX
|
-1.49 | $ 30.34 | -0.82 % | $ 286 B | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Akebia Therapeutics
AKBA
|
0.1 | $ 1.4 | -0.71 % | $ 360 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
62.6 | $ 95.5 | 3.83 % | $ 27.2 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 2.92 | -0.34 % | $ 6.35 B | ||
|
Aytu BioScience
AYTU
|
-0.39 | $ 2.55 | -0.78 % | $ 16 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 20.37 | -2.4 % | $ 952 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1.05 | - | -2.5 % | $ 5.88 M | ||
|
Aquestive Therapeutics
AQST
|
-0.66 | $ 4.08 | -2.16 % | $ 436 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 24.21 | -1.47 % | $ 3.08 B | ||
|
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
Celldex Therapeutics
CLDX
|
-4.28 | $ 32.24 | -4.1 % | $ 2.14 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
CymaBay Therapeutics
CBAY
|
-0.95 | - | - | $ 3.45 B | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Cabaletta Bio
CABA
|
-1.7 | $ 3.13 | -1.26 % | $ 315 M | ||
|
Codiak BioSciences
CDAK
|
-2.95 | - | -55.98 % | $ 2.15 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Avid Bioservices
CDMO
|
-0.12 | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
-27.7 | - | - | $ 1.41 B | ||
|
InflaRx N.V.
IFRX
|
-1.49 | $ 1.0 | -2.91 % | $ 152 M | ||
|
Immutep Limited
IMMP
|
-0.403 | $ 0.31 | -2.52 % | $ 1.08 B | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Checkpoint Therapeutics
CKPT
|
-1.42 | - | - | $ 169 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Concert Pharmaceuticals
CNCE
|
-2.21 | - | - | $ 401 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-0.67 | $ 3.83 | -2.3 % | $ 258 B | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Celsion Corporation
CLSN
|
-6.76 | - | -6.63 % | $ 13.9 M |